1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gastroenteropancreatic Neuroendocrine Tumor
1.2.3 Foregut Neuroendocrine Tumor
1.2.4 Midgut Neuroendocrine Tumor
1.2.5 Hindgut Neuroendocrine Tumor
1.3 Market by Application
1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2017-2028)
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Region
2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Region (2017-2022)
2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Region (2023-2028)
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Dynamics
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends
2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
2.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
2.3.4 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue
3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2017-2022)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2017-2022)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
3.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2021
3.5 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
3.6 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
3.7 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Type
4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2017-2022)
4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2023-2028)
5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application
5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Application (2017-2022)
5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2017-2028)
6.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
6.2.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
6.2.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028)
6.2.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2017-2028)
6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
6.3.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
6.3.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028)
6.3.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2017-2028)
6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
6.4.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022)
6.4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2017-2028)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
7.2.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
7.2.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028)
7.2.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2017-2028)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
7.3.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
7.3.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028)
7.3.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2017-2028)
7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
7.4.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022)
7.4.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2017-2028)
8.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
8.2.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2017-2028)
8.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
8.3.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2017-2028)
8.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region
8.4.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2017-2028)
9.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
9.2.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
9.2.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028)
9.2.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2017-2028)
9.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
9.3.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
9.3.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028)
9.3.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2017-2028)
9.4 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
9.4.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022)
9.4.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2017-2028)
10.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
10.2.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2017-2028)
10.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
10.3.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2017-2028)
10.4 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
10.4.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 ITM Solucin
11.2.1 ITM Solucin Company Details
11.2.2 ITM Solucin Business Overview
11.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
11.2.5 ITM Solucin Recent Developments
11.3 National Institutes of Health
11.3.1 National Institutes of Health Company Details
11.3.2 National Institutes of Health Business Overview
11.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
11.3.5 National Institutes of Health Recent Developments
11.4 Australasian Gastro-Intestinal Trials Group
11.4.1 Australasian Gastro-Intestinal Trials Group Company Details
11.4.2 Australasian Gastro-Intestinal Trials Group Business Overview
11.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
11.4.5 Australasian Gastro-Intestinal Trials Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 3. Key Players of Foregut Neuroendocrine Tumor
Table 4. Key Players of Midgut Neuroendocrine Tumor
Table 5. Key Players of Hindgut Neuroendocrine Tumor
Table 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2017-2022)
Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2023-2028)
Table 12. Peptide Receptor Radionuclide Therapy (PRRT) Market Trends
Table 13. Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints
Table 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Players (2017-2022)
Table 18. Global Top Peptide Receptor Radionuclide Therapy (PRRT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2021)
Table 19. Ranking of Global Top Peptide Receptor Radionuclide Therapy (PRRT) Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
Table 23. Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2017-2022)
Table 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2023-2028)
Table 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Application (2017-2022)
Table 31. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Application (2023-2028)
Table 33. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 66. Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. ITM Solucin Company Details
Table 69. ITM Solucin Business Overview
Table 70. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 71. ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022) & (US$ Million)
Table 72. ITM Solucin Recent Developments
Table 73. National Institutes of Health Company Details
Table 74. National Institutes of Health Business Overview
Table 75. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 76. National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022) & (US$ Million)
Table 77. National Institutes of Health Recent Developments
Table 78. Australasian Gastro-Intestinal Trials Group Company Details
Table 79. Australasian Gastro-Intestinal Trials Group Business Overview
Table 80. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 81. Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022) & (US$ Million)
Table 82. Australasian Gastro-Intestinal Trials Group Recent Developments
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type: 2021 VS 2028
Figure 2. Gastroenteropancreatic Neuroendocrine Tumor Features
Figure 3. Foregut Neuroendocrine Tumor Features
Figure 4. Midgut Neuroendocrine Tumor Features
Figure 5. Hindgut Neuroendocrine Tumor Features
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region: 2021 VS 2028
Figure 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players in 2021
Figure 15. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2021
Figure 17. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2028)
Figure 19. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2028)
Figure 20. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Country (2017-2028)
Figure 21. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2028)
Figure 25. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2028)
Figure 26. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Country (2017-2028)
Figure 27. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Region (2017-2028)
Figure 37. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Country (2017-2028)
Figure 47. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Country (2017-2028)
Figure 53. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Novartis Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
Figure 57. ITM Solucin Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
Figure 58. National Institutes of Health Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
Figure 59. Australasian Gastro-Intestinal Trials Group Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
